Ledger.Open graph →

SEC Form D · Amendment · filed March 7, 2011

Rosetta Genomics Ltd

Offering

$2.5M

Sold

$2.5M

Exemption

—

Industry

Biotechnology

Location

REHOVOT, L3

Type

—

People & firms on this filing (32)

Moshe Many · Rehovot, L3Director Tzipora S. Kupitz · Rehovot, L3Exec Brian A. Markison · Rehovot, L3Director Yoav Chelouche · Rehovot, L3Director Tami F. Jutkowitz · Rehovot, L3Exec Keren Givli · Rehovot, L3Exec Joshua Rosensweig · Rehovot, L3Director Tali Yaron-Eldar · Rehovot, L3Director David Sidransky · Rehovot, L3Director Tina Edmonston · Rehovot, L3Exec Racheli Vizman · Rehovot, L3Exec Isaac Bentwich · Rehovot, L3Director Ranit Aharonov · Rehovot, L3Exec Gerald Dogon · Rehovot, L3Director Kenneth Berlin · Rehovot, L3Exec · Director Ayelet Chajut · Rehovot, L3Exec Jeffrey E. Murphy · Prides Crossing, MAExec · Director Curt J. Ketterer · Pasadena, CAExec Jeremy Miller · New York, NYExec David Martirano · New York, NYExec Gardiner Garrard · Atlanta, GAExec Dan Drechsel · Atlanta, GAExec Brian Hirsch · Atlanta, GAExec John Chandy · Atlanta, GAExec Juan P. Espinosa · DALLAS, TXDirector Danny Tabally · DALLAS, TXDirector Jason Ashton · Santa Cruz, CADirector Jared T. Hardy · Fargo, NDDirector John Bivona · New York, NYDirector Mynul H. Khan · Minneapolis, MNDirector Colin Shaw · West Bay Road, PO Box 10173, Cayman IslandsDirector Chris Drake · Richardson, TXDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗